LT3543B - Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin - Google Patents

Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin Download PDF

Info

Publication number
LT3543B
LT3543B LTIP1534A LTIP1534A LT3543B LT 3543 B LT3543 B LT 3543B LT IP1534 A LTIP1534 A LT IP1534A LT IP1534 A LTIP1534 A LT IP1534A LT 3543 B LT3543 B LT 3543B
Authority
LT
Lithuania
Prior art keywords
galacturonic acid
cholesterol
acid
treatment
prophylaxis
Prior art date
Application number
LTIP1534A
Other languages
English (en)
Lithuanian (lt)
Inventor
Hans-Ludwig Schaefer
Werner Schneider
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of LTIP1534A publication Critical patent/LTIP1534A/xx
Publication of LT3543B publication Critical patent/LT3543B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
LTIP1534A 1990-04-06 1993-12-06 Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin LT3543B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011285A DE4011285A1 (de) 1990-04-06 1990-04-06 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose

Publications (2)

Publication Number Publication Date
LTIP1534A LTIP1534A (en) 1995-06-26
LT3543B true LT3543B (en) 1995-11-27

Family

ID=6403968

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1534A LT3543B (en) 1990-04-06 1993-12-06 Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin

Country Status (17)

Country Link
US (1) US5434141A (fr)
EP (1) EP0476113B1 (fr)
JP (1) JPH05500673A (fr)
KR (1) KR920700656A (fr)
AT (1) ATE135223T1 (fr)
AU (1) AU639097B2 (fr)
CA (1) CA2063588A1 (fr)
DE (2) DE4011285A1 (fr)
DK (1) DK0476113T3 (fr)
ES (1) ES2086538T3 (fr)
GR (1) GR3019866T3 (fr)
HU (1) HU218925B (fr)
LT (1) LT3543B (fr)
LV (1) LV10839B (fr)
RU (1) RU2108788C1 (fr)
UA (1) UA35566C2 (fr)
WO (1) WO1991015214A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
JPH0948732A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
ATE218065T1 (de) * 1996-08-09 2002-06-15 Mannatech Inc Zusammensetzungen auf pflanzliicher kohlenhydratbasis als nahrungsergänzungsstoffe
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
WO2008011216A2 (fr) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Polysaccharides à dents de galactose dans une formulation pour des thérapies antifibrotiques
WO2012138213A1 (fr) * 2011-04-08 2012-10-11 N.V. Nutricia Réduction d'un dysfonctionnement vasculaire avec des saccharides spécifiques
EP2755480B1 (fr) * 2011-09-16 2021-03-31 Galectin Therapeutics Inc. Utilisation de compositions de galacto-rhamno-galacturonate pour traiter la stéatohépatite non alcoolique et la stéatose hépatique non alcoolique
BR112014030534A2 (pt) 2012-06-06 2017-06-27 Galectin Therapeutics Inc composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370961A (en) * 1941-11-15 1945-03-06 Rohm & Haas Preparation of alpha-d-galacturonic acid
DE2036605A1 (de) * 1970-07-23 1972-05-31 Mylaeus, Armin, 5970 Plettenberg Diätbrot und Verfahren zu seiner Herstellung
DE2521765B2 (de) * 1975-05-16 1979-01-18 Valentin Dr.Med. Koehler Verwendung von D-Glucuronsäure, dessen γ -Lacton, Galacturonsäure oder Mannuronsäure
US4122179A (en) * 1976-06-03 1978-10-24 Enrico Corvi Mora Acid addition salts of vincamine and apovincamine
JPS54119038A (en) * 1978-03-07 1979-09-14 Takeda Chemical Industries Ltd Digestion difficult polysaccaride containing food
FR2449452A1 (fr) * 1978-11-15 1980-09-19 Krauter Henri Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique
JPS59206045A (ja) * 1983-05-11 1984-11-21 Asahi Chem Ind Co Ltd 低比重リポ蛋白質吸着材
DD271415A3 (de) * 1983-07-05 1989-09-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines pektindiaetetikums
US4617276A (en) * 1985-01-23 1986-10-14 Agway Inc. Novel method for quantitating structural and non-structural carbohydrates in feedstuffs
US4615891A (en) * 1985-01-23 1986-10-07 Agway Inc. Method of formulating dairy cow rations based on carbohydrate regulation
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
DK81690D0 (da) * 1990-03-30 1990-03-30 Grindsted Prod As Pektinprodukt og fremgangsmaade til fremstilling deraf

Also Published As

Publication number Publication date
GR3019866T3 (en) 1996-08-31
UA35566C2 (uk) 2001-04-16
JPH05500673A (ja) 1993-02-12
AU639097B2 (en) 1993-07-15
RU2108788C1 (ru) 1998-04-20
EP0476113A1 (fr) 1992-03-25
HU218925B (hu) 2000-12-28
ES2086538T3 (es) 1996-07-01
ATE135223T1 (de) 1996-03-15
LV10839B (en) 1996-04-20
CA2063588A1 (fr) 1991-10-07
LV10839A (lv) 1995-10-20
US5434141A (en) 1995-07-18
DE4011285A1 (de) 1991-10-10
LTIP1534A (en) 1995-06-26
HUT61199A (en) 1992-12-28
DK0476113T3 (da) 1996-07-15
EP0476113B1 (fr) 1996-03-13
KR920700656A (ko) 1992-08-10
WO1991015214A1 (fr) 1991-10-17
DE59107536D1 (de) 1996-04-18
AU7664991A (en) 1991-10-30
HU913814D0 (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DE69910559T2 (de) Neue fettanaloge zur behandlung der fettleibigkeit
DE69721766T2 (de) Neue arzneiformulierung
DE69530910T4 (de) Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
US4703062A (en) Parenteral nutrition with medium and long chain triglycerides
LT3543B (en) Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin
WO1990014829A1 (fr) Derives de lysolecithine pour le traitement de maladies auto-immunitaires
Hallberg et al. Effects of long‐term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse
DE3786304T2 (de) Immunostimulierende Arzneimittel.
JP2001511447A (ja) Ｌ−カルニチンまたはアルカノイルｌ−カルニチンおよび長鎖アルカノイルを含む組成物
EP0488928B1 (fr) Médicament contenant des mélanges d'alcools aliphatiques primaires à chaines longues, pour traiter l'hypercholésterolémie et l'hyperlipoprotéinémie du type II et pour stimuler le comportement sexuel des animaux et des hommes
US4914121A (en) 3-Phenyl-1-phenylpyrazole-4 acetic acid compounds which are useful in treating immune diseases
EP0219156A1 (fr) Composition tempérant l'appétit et ayant une activité anti-gastrite
DE3311922C2 (de) Verwendung von substituierten 1,4-Benzochinonen bei der Prophylaxe oder Behandlung von Fibrose
DE2559989C3 (de) Polymere und Verfahren zu ihrer Herstellung
JP3050898B2 (ja) 水性医薬製剤
DE60128801T2 (de) Isoflavone gegen strahlungsinduzierte Sterblichkeit
JP4742489B2 (ja) 高トリグリセライド血症の予防または改善用組成物
Hosokawa et al. EFFECT OF ASCOFURANONE ON SERUM LIPIDSOF RATS FED A CHOLESTEROL RICH DIET
CN109700797B (zh) 一种减肥的药物组合物及其制备方法与用途
DE60202446T2 (de) Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen
DE69300945T2 (de) Fettstoffwechsel verbessernde Zusammensetzung.
US3574853A (en) Composition and method of reducing serum cholesterol with thiobiscresols
DE60117472T2 (de) Pharmazeutische zusammensetzung zur behandlung von fettleibigkeit
JP2893807B2 (ja) アズレン誘導体含有液剤
DE69734356T2 (de) Diclofenac zur behandlung von vasculopathien

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20001206